Stock Movers: Corcept Therapeutics Soars, Abbott Labs Sinks, Arista Networks Jumps

Corcept Therapeutics (CORT) Stock Surge

• 💡 Corcept Therapeutics shares jumped approximately 15% after their Phase 3 ROSELLA trial for a drug in platinum-resistant ovarian cancer met its primary endpoint.
• 🎯 The trial showed a 35% reduction in death risk when the drug was used in combination with nab-paclitaxel, compared to nab-paclitaxel alone.
• ⚠️ The FDA is currently reviewing the drug's new drug application with a target date of July.
• 📉 Despite the recent surge, the stock is still recovering from a sharp fall in late December, when the FDA rejected the company's drug for a specific form of high blood pressure.

Abbott Labs (ABT) Stock Decline

• 📉 Abbott Labs was the worst performer in the S&P 500, down 7.3%, marking its worst performance since July.
• 📊 The medical devices firm reported fourth-quarter sales that fell short of estimates and provided a first-quarter earnings forecast that missed Wall Street expectations.
• 💰 The company has faced weakness due to offering discounts on nutrition products to price-conscious customers, including protein drinks for those on weight loss drugs.
• ⚠️ Analysts had already anticipated some conservative guidance following the impact of COVID-19 testing sales.

Arista Networks (ANET) Stock Rally

• 🚀 Arista Networks was the top performer in the S&P 500, up 10%, marking its best intraday performance since August.
• ⚡ The rally may be partly driven by broader strength in memory stocks, with a recent analyst note placing Arista in that sector.
• 🔍 While Arista is performing well, other companies in the memory sector, such as SanDisk, Seagate, and Western Digital, were down on the same day, leaving the exact reasons for Arista's jump unclear.